Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 172

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer

Open access
Maguire, Roma, Fox, Patricia A, McCann, Lisa, Miaskowski, Christine, Kotronoulas, Grigorios, Miller, Morven, Furlong, Eileen, Ream, Emma, Armes, Jo, Patiraki, Elisabeth, Gaiger, Alexander, Berg, Geir V, Flowerday, Adrian, Donnan, Peter, McCrone, Paul, Apostolidis, Kathi, Harris, Jenny, Katsaragakis, Stylianos, Buick, Alison R, Kearney, Nora · 2017 · BMJ Open

Abstract

Introduction: While some evidence exists that real-time remote symptom monitoring devices can decrease morbidity and prevent unplanned admissions in oncology patients, overall, these studies have significant methodological weaknesses. The electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology (eSMART) study is designed to specifically address these weaknesses with an appropriately powered, repeated-measures, parallel-group stratified randomised controlled trial of oncology patients. Methods and analysis: A total of 1108 patients scheduled to commence first-line chemotherapy (CTX) for breast, colorectal or haematological cancer will be recruited from multiple sites across five European countries. Patients will be randomised (1:1) to the ASyMS intervention (intervention group) or to standard care currently available at each site (control group). Patients in the control and intervention groups will complete a demographic and clinical questionnaire, as well as a set of valid and reliable electronic patient-reported outcome measures at enrolment, after each of their CTX cycles (up to a maximum of six cycles) and at 3, 6, 9 and 12 months after completion of their sixth cycle of CTX. Outcomes that will be assessed include symptom burden (primary outcome), quality of life, supportive care needs, anxiety, self-care self-efficacy, work limitations and cost effectiveness and, from a health professional perspective, changes in clinical practice (secondary outcomes). Ethics and dissemination: Ethical approval will be obtained prior to the implementation of all major study amendments. Applications will be submitted to all of the ethics committees that granted initial approval. eSMART received approval from the relevant ethics committees at all of the clinical sites across the five participating countries. In collaboration with the European Cancer Patient Coalition (ECPC), the trial results will be disseminated through publications in scientific journals, presentations at international conferences, and postings on the eSMART website and other relevant clinician and consumer websites; establishment of an eSMART website (www.esmartproject.eu) with publicly accessible general information; creation of an eSMART Twitter Handle, and production of a toolkit for implementing/utilising the ASyMS technology in a variety of clinical practices and other transferable health care contexts. Trial registration number: NCT02356081.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2016-015016

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 46

  1. 10.1080/02841860151116349 · DOI · Paper page
  2. 10.1001/archinternmed.2007.125 · doi:10.1001/archinternmed.2007.125
  3. 10.1038/bjc.2012.228 · doi:10.1038/bjc.2012.228
  4. 10.1200/JCO.2013.49.4757 · DOI · Paper page
  5. 10.1007/s00520-004-0710-6 · DOI · Paper page
  6. 10.1089/jayao.2014.0023 · DOI
  7. 10.1002/cncr.21847 · DOI · Paper page
  8. 10.1007/s00520-014-2553-0 · doi:10.1007/s00520-014-2553-0
  9. Chindaprasirt, 2013, Mortality, length of stay, and cost associated with hospitalized adult Cancer patients with febrile neutropenia, Asian Pac J Cancer Prev, 14, 1115, 10.7314/APJCP.2013.14.2.1115 · doi:10.7314/apjcp.2013.14.2.1115
  10. 10.1177/1078155211436022 · DOI
  11. 10.1093/annonc/mdq759 · DOI
  12. 10.1007/s00520-010-0913-y · DOI
  13. 10.1188/07.ONF.1162-1167 · doi:10.1188/07.onf.1162-1167
  14. 10.1007/s00520-012-1448-1 · DOI · Paper page
  15. 10.1007/s00520-010-1073-9 · doi:10.1007/s00520-010-1073-9
  16. Husson, 2015, Variation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry, Support Care Cancer, 23, 2165, 10.1007/s00520-014-2577-5 · DOI
  17. 10.1188/12.ONF.E31-E40 · DOI
  18. 10.1016/S0020-7489(00)00106-1 · DOI
  19. 10.1186/1477-7525-8-65 · DOI
  20. Coolbrandt, 2011, Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: does timing matter?, Eur J Oncol Nurs, 15, 130, 10.1016/j.ejon.2010.06.010 · DOI
  21. 10.1016/j.ejon.2011.02.005 · DOI
  22. Kotronoulas, 2012, Informal carers: a focus on the real caregivers of people with Cancer, Forum Clin Oncol, 3, 58
  23. Butow, 2012, Psychosocial well-being and supportive care needs of Cancer patients living in urban and rural/regional areas: a systematic review, Support Care Cancer, 20, 1, 10.1007/s00520-011-1270-1 · DOI · Paper page
  24. 10.1097/PPO.0b013e31822c28b3 · DOI
  25. 10.1188/08/ONF.661-669 · DOI
  26. 10.1200/JOP.2013.001067 · DOI · Paper page
  27. 10.1016/j.ejon.2009.03.004 · DOI
  28. 10.1097/NCC.0b013e3181cb4bad · DOI
  29. 10.1007/s00520-005-0002-9 · DOI
  30. 10.1177/1744987108099235 · DOI
  31. 10.1016/j.ejon.2008.04.007 · DOI
  32. Maguire, 2005, Results of a UK based pilot study of a mobile phone based advanced symptom management system (ASyMS) in the remote monitoring of chemotherapy related toxicity, Clin Eff Nurs, 9, 202, 10.1016/j.cein.2006.08.013 · DOI
  33. 10.12968/ijpn.2008.14.9.31121 · DOI
  34. 10.1007/s11136-008-9396-4 · DOI · Paper page
  35. 10.1007/s11136-008-9414-6 · DOI
  36. 10.3322/caac.21150 · DOI · Paper page
  37. Vickers, 2011, Prediction models in Cancer care, CA Cancer J Clin, 61, n/a, 10.3322/caac.20118 · DOI
  38. Kofoed, 2012, Benefits of remote real-time side-effect monitoring systems for patients receiving Cancer treatment, Oncol Rev, 6, 7, 10.4081/oncol.2012.e7 · DOI
  39. 10.1016/0959-8049(94)90182-1 · DOI · Paper page
  40. 10.1111/j.1365-2753.2008.01057.x · DOI · Paper page
  41. 10.1016/j.pec.2004.09.005 · DOI
  42. 10.1016/S0895-4356(01)00424-3 · DOI · Paper page
  43. McCann, 2009, Patients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity, Eur J Cancer Care, 18, 156, 10.1111/j.1365-2354.2008.00938.x · DOI · Paper page
  44. 10.1016/j.ijnurstu.2012.09.009 · DOI · Paper page
  45. 10.1186/1472-6963-10-180 · DOI
  46. 10.1097/NCC.0b013e31824d90d4 · DOI · Paper page

Cited by

Metadata

Authors
Maguire, R., Fox, P. A., McCann, L., Miaskowski, C., Kotronoulas, G., Miller, M., Furlong, E., Ream, E., Armes, J., Patiraki, E., Gaiger, A., Berg, G. V., Flowerday, A., Donnan, P., McCrone, P., Apostolidis, K., Harris, J., Katsaragakis, S., Buick, A. R., & Kearney, N.
Venue
BMJ Open
Publisher
BMJ
Published
2017-05
Volume
7
Issue
5
Pages
e015016
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2604093837
Cited by
172
References
9
FWCI
10.34
Type
journal article
Language
en
Open access
gold
Funders
Seventh Framework Programme

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.